Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer
- Sai Hong Ignatius Ou
- , Shirish M. Gadgeel
- , Fabrice Barlesi
- , James Chih Hsin Yang
- , Luigi De Petris
- , Dong Wan Kim
- , Ramaswamy Govindan
- , Anne Marie Dingemans
- , Lucio Crino
- , Hervé Léna
- , Sanjay Popat
- , Jin Seok Ahn
- , Eric Dansin
- , Emmanuel Mitry
- , Barbara Müller
- , Walter Bordogna
- , Bogdana Balas
- , Peter N. Morcos
- , Alice T. Shaw
- University of California at Irvine
- University of Michigan, Ann Arbor
- Aix-Marseille University
- National Taiwan University
- Karolinska Institutet
- Seoul National University
- Washington University St. Louis
- Maastricht University
- Istituto Scientifico Romagnolo
- Hôpital Pontchaillou
- Royal Marsden NHS Foundation Trust
- Centre Oscar Lambret
- F. Hoffmann-La Roche AG
- Roche Innovation Center
- Massachusetts General Hospital Cancer Center
Research output: Contribution to journal › Article › peer-review
35
Link opens in a new tab
Scopus
citations